Skip to main content

BML Capital Management, LLC

13F filer · CIK 0001616824
Reported Aug 7, 2026
Net seller this quarter
13F portfolio value$176MU.S. long equity reported on 13F
Positions151 new · 1 closed
Net flow last quarter-$5.38MBuys minus sells
Top 10 positions weight93.3%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 7, 202615 positions
ACRSAclaris Therapeutics, Inc.$63.3M35.98%8.56%-16.0%Q4 2023
AVIRAtea Pharmaceuticals, Inc.$32.3M18.36%8.67%-1.5%Q2 2023
ENGNenGene Therapeutics Inc.$11.5M6.55%9.96%NewQ2 2026
KHCKraft Heinz Co$11M6.24%0.04%+272.0%Q1 2026
OMOutset Medical, Inc.$10.9M6.18%13.40%+32.5%Q4 2025
KMXCarmax Inc$9.12M5.18%0.12%+11.3%Q4 2025
TLYSTilly'S, Inc.$9.03M5.13%17.95%Not reportedQ4 2022
PMVPPMV Pharmaceuticals, Inc.$7.14M4.06%9.97%+0.2%Q1 2024
TILInstil Bio, Inc.$4.96M2.82%9.52%Not reportedQ1 2024
TGTTarget Corp$4.9M2.78%0.01%Not reportedQ3 2025
ORMPOramed Pharmaceuticals Inc.$4.17M2.37%2.10%-72.7%Q1 2023
JANXJanux Therapeutics, Inc.$2.38M1.35%0.25%Not reportedQ1 2026
PLRXPliant Therapeutics, Inc.$1.76M1.00%2.50%Not reportedQ4 2025
CNTBConnect Biopharma Holdings Ltd$1.36M0.78%0.91%+40.2%Q4 2023
IMAImageneBio, Inc.$1.18M0.67%1.78%Not reportedQ3 2025
Q1 2026Reported May 6, 202615 positions
ACRSAclaris Therapeutics, Inc.$53.4M34.31%10.20%Not reportedQ4 2023
AVIRAtea Pharmaceuticals, Inc.$38M24.38%8.82%-5.8%Q2 2023
ORMPOramed Pharmaceuticals Inc.$10.8M6.91%7.74%Not reportedQ1 2023
TLYSTilly'S, Inc.$8.71M5.59%17.95%Not reportedQ4 2022
OMOutset Medical, Inc.$7.3M4.69%10.27%+250.2%Q4 2025
PMVPPMV Pharmaceuticals, Inc.$6.6M4.24%9.98%+0.5%Q1 2024
KMXCarmax Inc$6.44M4.14%0.11%Not reportedQ4 2025
KZRKezar Life Sciences, Inc.$5.35M3.43%9.77%Not reportedQ4 2024
TILInstil Bio, Inc.$5.32M3.42%9.52%Not reportedQ1 2024
TGTTarget Corp$4.55M2.92%0.01%Not reportedQ3 2025
KHCKraft Heinz Co$2.81M1.80%0.01%NewQ1 2026
JANXJanux Therapeutics, Inc.$2.15M1.38%0.25%NewQ1 2026
PLRXPliant Therapeutics, Inc.$1.95M1.25%2.50%Not reportedQ4 2025
CNTBConnect Biopharma Holdings Ltd$1.07M0.69%0.65%Not reportedQ4 2023
IMAImageneBio, Inc.$1M0.64%1.80%+13.4%Q3 2025
Q4 2025Reported Feb 3, 202613 positions
ACRSAclaris Therapeutics, Inc.$42.9M37.08%11.83%Not reportedQ4 2023
AVIRAtea Pharmaceuticals, Inc.$26.7M23.11%9.59%+0.2%Q2 2023
ORMPOramed Pharmaceuticals Inc.$9.03M7.80%8.06%Not reportedQ1 2023
TILInstil Bio, Inc.$7.1M6.14%9.52%Not reportedQ1 2024
PMVPPMV Pharmaceuticals, Inc.$6.62M5.72%9.92%Not reportedQ1 2024
KMXCarmax Inc$5.99M5.18%0.11%NewQ4 2025
KZRKezar Life Sciences, Inc.$4.53M3.92%9.83%Not reportedQ4 2024
TGTTarget Corp$3.67M3.17%0.01%+275.0%Q3 2025
OMOutset Medical, Inc.$2.02M1.74%2.99%NewQ4 2025
PLRXPliant Therapeutics, Inc.$1.89M1.63%2.52%NewQ4 2025
IMAImageneBio, Inc.$1.22M1.06%1.58%-3.0%Q3 2025
CNTBConnect Biopharma Holdings Ltd$1.15M1.00%0.72%-67.7%Q4 2023
LSTALisata Therapeutics, Inc.$136K0.12%0.83%-33.2%Q4 2022
Q3 2025Reported Nov 10, 202518 positions
ACRSAclaris Therapeutics, Inc.$27.1M24.79%13.15%Not reportedQ4 2023
AVIRAtea Pharmaceuticals, Inc.$21.7M19.85%9.57%-1.8%Q2 2023
ADVMAdverum Biotechnologies, Inc.$13.9M12.68%14.57%Not reportedQ4 2022
TILInstil Bio, Inc.$11.5M10.56%9.52%+20.7%Q1 2024
ORMPOramed Pharmaceuticals Inc.$8.36M7.66%7.76%+2.7%Q1 2023
PMVPPMV Pharmaceuticals, Inc.$7.41M6.78%9.99%+5.8%Q1 2024
ALMSAlumis Inc.$4.83M4.42%Not reportedNot reportedQ1 2025
LVTXLAVA Therapeutics NV$3.07M2.81%7.49%Not reportedQ1 2025
KZRKezar Life Sciences, Inc.$2.81M2.57%9.84%+13.5%Q4 2024
CNTBConnect Biopharma Holdings Ltd$1.91M1.75%2.27%-30.4%Q4 2023
IMAImageneBio, Inc.$1.49M1.36%4.54%NewQ3 2025
LONALeonaBio, Inc.$1.34M1.22%8.19%NewQ3 2025
ASTCASTROTECH Corp$1.08M0.99%12.53%Not reportedQ4 2022
TGTTarget Corp$897K0.82%0.00%NewQ3 2025
VTGNVistagen Therapeutics, Inc.$533K0.49%0.49%Not reportedQ3 2023
ARVNArvinas, Inc.$426K0.39%0.07%NewQ3 2025
LSTALisata Therapeutics, Inc.$288K0.26%1.25%-47.7%Q4 2022
MURAMural Oncology plc$119K0.11%0.33%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.